BD Announces CE Marking Of A New Molecular Test To Diagnose Patients With Clostridium Difficile Infections

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced the CE marking of the BD GeneOhm(TM) Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection (CDI). It is the first CDI diagnostic test that offers sensitivity, simplicity and speed in one test procedure. BD has also submitted this assay to the U.S. Food and Drug Administration for clearance.

More: continued here

Comments are closed.



RX Pill Vault - Buy Drugs: Interested in buying Rx pills? Here is the link for you.
Drug store online - Drug store online: Pills form drugs store online
Medical rx pill - : Medical rx pill
Prescript aware - : Prescript aware
Rx store online - : Rx store online
Latest News...